aminoimidazole carboxamide has been researched along with Cancer of Liver in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ganapathy, V; Higuchi, K; Kopel, J; Ramachandran, S; Ristic, B; Sato, T | 1 |
| Gao, J; Jiang, G; Xiong, D; Xiong, R; Yin, T; Yin, Z; Zhang, S; Zhang, X; Zhao, W | 1 |
| Cai, B; Cai, X; Chen, X; Cheng, J; Hu, H; Hu, X; Huang, J; Jing, X; Li, Y; Tan, X; Wang, Q | 1 |
| Chen, W; Cheng, J; Cheng, W; Guo, Y; Huang, J; Huang, T; Jing, X; Li, Y; Tan, X; Wang, Q; Yamamoto, T; Zhang, Y; Zhu, Y | 1 |
| Calderon, PB; Dejeans, N; Glorieux, C; Najimi, M; Renard, P; Rommelaere, G; Sid, B; Valenzuela, M; Verrax, J | 1 |
| Gao, R; Goswami, R; Li, Q; Liu, L; Lv, Q; Yang, S; Zhen, Q; Zhou, H | 1 |
| Ka, SO; Kim, JH; Kim, SJ; Park, BH; Park, JH; Shen, C | 1 |
| Cooksey, RC; Landaker, E; McClain, D; Park, J; Patti, ME; Ruddock, MW; Stein, A | 1 |
| Crabb, DW; Liangpunsakul, S; Lu, C; Sozio, MS; Zeng, Y | 1 |
| Chiesara, E; Ferraris, M; Gervasoni, M; Marabini, L; Radice, S | 1 |
| Avery, LN; Brockman, RW; Montgomery, JA; Thomas, HJ | 1 |
11 other study(ies) available for aminoimidazole carboxamide and Cancer of Liver
| Article | Year |
|---|---|
The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin.
Topics: Aminoimidazole Carboxamide; Carcinoma, Hepatocellular; Citric Acid; Gene Expression Regulation, Neoplastic; Glycolysis; Hep G2 Cells; Humans; Hypoglycemic Agents; Liver Neoplasms; Metformin; Molecular Targeted Therapy; Ribonucleotides; Signal Transduction; Symporters; TOR Serine-Threonine Kinases | 2020 |
The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Topics: Adenosine Monophosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Diet, High-Fat; Diethylnitrosamine; Disease Models, Animal; Fatty Liver; Interleukin-6; Lipid Metabolism; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Ribonucleotides; STAT3 Transcription Factor; Triglycerides | 2018 |
Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Topics: Aminoimidazole Carboxamide; Animals; Carcinoma, Hepatocellular; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Mice; Ribonucleotides; Xenograft Model Antitumor Assays | 2013 |
AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Heterografts; Humans; Hypoglycemic Agents; Ki-67 Antigen; Liver Neoplasms; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Ribonucleotides | 2014 |
AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells.
Topics: Active Transport, Cell Nucleus; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; NF-E2-Related Factor 2; Phosphorylation; Pyrones; Ribonucleosides; Thiophenes | 2014 |
AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Metformin; Phosphorylation; Ribonucleotides; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2015 |
Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Humans; Hypoglycemic Agents; Liver Neoplasms; MAP Kinase Signaling System; Metformin; Nanog Homeobox Protein; Real-Time Polymerase Chain Reaction; Ribonucleotides | 2016 |
Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling.
Topics: Aminoimidazole Carboxamide; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Fatty Acids; Fatty Acids, Nonesterified; Forkhead Transcription Factors; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Liver; Liver Neoplasms; Mice; Mice, Knockout; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Receptor, Insulin; Ribonucleotides; Signal Transduction; Triazenes | 2008 |
Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Liver Neoplasms; Metformin; PPAR alpha; PPAR gamma; Rats; Ribonucleosides; Rosiglitazone; Thiazolidinediones; Transcriptional Activation | 2011 |
Adaptation to oxidative stress: effects of vinclozolin and iprodione on the HepG2 cell line.
Topics: Adaptation, Physiological; Aminoimidazole Carboxamide; Carcinoma, Hepatocellular; Fungicides, Industrial; Glutamate-Cysteine Ligase; Glutathione; Humans; Hydantoins; Lipid Peroxidation; Liver Neoplasms; Oxazoles; Oxidative Stress; Tumor Cells, Cultured | 1998 |
5-Amino-4-(diazoacetyl)-1-beta-D-ribofuranosylimidazole, a new antileukemic agent.
Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Humans; Imidazoles; Indicators and Reagents; Leukemia L1210; Liver Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Ribonucleosides; Structure-Activity Relationship | 1987 |